Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering

Go back to Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
(NASDAQ: ZNTL) Delayed: 2.70 --0 (-0%)
Previous Close $2.70    52 Week High $ 
Open $2.70    52 Week Low $ 
Day High $2.70    P/E N/A 
Day Low $2.70    EPS $ 
Volume 60